Medichem

Medichem is a vertically integrated European pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), with a strong focus on generics. The company has over five decades of experience, operates globally with more than 600 customers in over sixty countries, and holds leadership positions particularly in chlorhexidine-based products. Its portfolio includes around forty-five APIs and twenty FDFs currently marketed or licensed worldwide. The company invests heavily in R&D (~10% of turnover), maintains an extensive intellectual property portfolio (~80 patents/applications), operates FDA-inspected GMP facilities in Spain and Malta, and has a robust record for regulatory compliance.